痰湿证多囊卵巢综合征患者血清瘦素、TNF-α水平与胰岛素抵抗关系的研究
|
摘要
目的
多囊卵巢综合征(polycystic ovary syndrome,PCOS)是以雄激素过多及长期无排卵为特征,是育龄妇女常见的一种极为复杂的内分泌及糖代谢异常所致的病理状态,发病率为5%～10%。最近认识到PCOS不仅涉及生殖系统,而且是一种代谢综合征,常发生高胰岛素血症(High Insulin,HI)、高血脂、糖尿病和心血管疾病,在治疗上涉及月经失调、生育问题、内膜增生、远期代谢合并征等多学科问题。PCOS患者中大约50%超重或肥胖,该型患者代谢紊乱发病率明显高于非肥胖型,而且程度也重于非肥胖型患者。然而肥胖型PCOS患者的治疗仍相当棘手。中医学认为“脾虚不运,痰湿阻滞”为肥胖之根本,现代研究表明这也是PCOS患者胰岛素抵抗(insulinresistance,IR)和代谢紊乱发生的重要病理基础。
近年来随着对PCOS病因病机研究的不断深入,学者们发现PCOS患者不仅存在脂肪量的增多,同时还存在脂肪细胞因子分泌的异常,脂肪中分泌的多种激素信号调节分子与PCOS导致的代谢紊乱及内分泌紊乱存在一定的关系。本组主要通过观察痰湿证PCOS肥胖患者的体重指数(body mass index,BMI)、月经异常、痤疮及多毛评分情况,同时检测促卵泡激素(follicle-stimulating hormone,FSH)、促黄体激素(luteinizing hormone,LH)、睾酮(testosterone,T)、空腹血糖(fasting serumglucose,FPG)、空腹胰岛素(fasting serum insulin,FINS)、瘦素、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α),计算胰岛素敏感指数(insulin insentiveindex,ISI),并以痰湿肥胖体质妇女及非肥胖妇女为对照,旨在探讨痰湿证PCOS肥胖患者血清瘦素、TNF-α水平与IR的关系。
方法
选择2007年1月～2008年1月就诊于广州中医药大学第一附属医院妇科门诊及广东省第二中医院针灸减肥门诊就诊,确诊为痰湿证且肥胖的PCOS患者22例,平均年龄27.55岁。选择同期来针灸门诊减肥的年龄匹配的痰湿肥胖体质者20例(肥胖对照组),及前来体检的健康非肥胖妇女(非肥胖对照组)20例作为对照组。
观察指标:
1、观察并记录所有研究对象的一般情况,测量身高、体重,计算BMI,同时记录月经异常(月经稀发或闭经)、痤疮及多毛评分情况。
2、检测指标所有研究对象均于月经第3~5天(PCOS闭经者B超检查无优势卵泡)晨,空腹抽取肘静脉血8ml,检测FSH、LH、T、FPG、FINS、瘦素、TNF-α。计算ISI,计算方法:ISI=1/(FINS×FPG),ISI＜0.021为IR。
结果
1、痤疮评分在痰湿PCOS组明显高于肥胖对照组及非肥胖对照组(P＜0.05),在肥胖对照组、非肥胖对照组之间比较,差异无显著性(P＞0.05)。多毛评分在痰湿PCOS组、肥胖对照组明显高于非肥胖对照组(P＜0.05),在痰湿PCOS组、肥胖对照组之间比较,差异无显著性(P＞0.05)。
2、LH在痰湿PCOS组明显高于肥胖对照组及非肥胖对照组(P＜0.05),在肥胖对照组及非肥胖对照组间比较,差异无显著性(P＞0.05);FSH、LH/FSH在三组妇女间比较,差异无显著性(P＞0.05);T在痰湿PCOS组明显高于肥胖对照组及非肥胖对照组(P＜0.05),在肥胖对照组、非肥胖对照组之间比较,差异无显著性(P＞0.05)。
3、FPG在三组之间比较差异无显著性(P＞0.05);FINS在痰湿PCOS组明显高于肥胖对照组及非肥胖对照组(P＜0.05),在肥胖对照组明显高于非肥胖对照组(P＜0.05);ISI在痰湿PCOS组明显低于肥胖对照组及非肥胖对照组(P＜0.05),在肥胖对照组明显低于非肥胖对照组(P＜0.05)。
4、血清瘦素、TNF-α在痰湿PCOS组明显高于肥胖对照组及非肥胖对照组(P＜0.05),在肥胖对照组明显高于非肥胖对照组(P＜0.05)。
5、痰湿证PCOS肥胖患者瘦素水平与BMI呈显著正相关关系;与ISI呈显著负相关关系。TNF-α水平与BMI呈显著正相关关系;与ISI呈显著负相关关系。
结论
1、痰湿证PCOS肥胖患者具备HA、HI、IR。
2、痰湿证PCOS肥胖患者瘦素、TNF-α水平升高,与IR的发生关系密切。
Objectivs
Polycystic ovary syndrome(PCOS)is a common gynecologyical disease which can cause endocrinologic disorder and infertility in women of reproductive age,and its incidence is 5%～10%.It is also a kind of metabohsmsyndrome(MS),which has the feature of endocrinology such as High Insulin(HI),insulin resistance(IR),and can lead to Diabetes, Cardiovascular diseas.
Nearly 50%patients of PCOS is obese,who is easy to occurrence MS, and the treatment is difficult.Acorrding to the theroy of Traditional Chinese Medicine,"dysfucnction of spleen and phlegm stagnation" is the basis of obesity,and modern medcin also certificate that it' s the important patholoical basis of PCOS.
Now scholars find that fat cytokines is disorder in patiets with PCOS. The study is to ivestigate the the correlation of leptin,Tumor necrosis factor(TNF)-αwith insulin resistance in patients with PCOS of phlegmatic hygrosis.
Methods
Three groups were established,PHP group(22 cases with PCOS of phlegmatic hygrosis),OB group(20 cases with obese of phlegmatic hygrosis women),NOB group(20 cases with non-obese and healthy women).Condition of menstruation,acne,hairness Were observed,as the serum follicle-stimulating hormone(FSH),luteinizing hormone(LH), testosterone(T),fasting serum glucose(FPG),fasting serum insulin (FINS),leptin,TNF-αwere detected,and insulin sensitivity index(ISI), body mass index(BMI)were calculated.
Results
1.Acne score in PHP group was higher than that in OB group and NOB group(P＜0.05),and had no significant difference between the two controll group(P＞0.05).Hairness score in PHP group and OB group was was higher than that in NOB group(P＜0.05),and had no significant difference between PHP group and OB group(P＞0.05)
2.LH,T in PHP group was higher than that in OB group and NOB group (P＜0.05),and had no significant difference between the two controll group(P＞0.05).FSH,LH/FSH had no significant difference in three groups (P＞0.05).
3.FPG had no significant difference in three groups(P＞0.05).FINS in PHP group was higher than that in OB group and NOB group(P＜0.05), FINS in OB group was higher than that in NOB group(P＜0.05).ISI in PHP group was lower than that in OB group and NOB group(P＜0.05),ISI in OB group was lower than that in NOB group(P＜0.05).
4.Leptin,TNF-αin PHP group was higher than that in OB group and NOB group(P＜0.05),Leptin,TNF-αin OB group was higher than that in NOB group(P＜0.05).
5.Leptin,TNF-αhad direct ratio with BMI,as had negative ratio with ISI.
Conclusions
1.Obese patients with PCOS of phlegmatic hygrosis has the feature of endocrinology such as High Insulin(HI),insulin resistance(IR).
2.Leptin,TNF-αincreases in obses patients with PCOS of phlegmatic hygrosis.Leptin,TNF-αhas close correlation with obesity and IR in obese patients with PCOS of phlegmatic hygrosis.
多囊卵巢综合征(polycystic ovary syndrome,PCOS)是以雄激素过多及长期无排卵为特征,是育龄妇女常见的一种极为复杂的内分泌及糖代谢异常所致的病理状态,发病率为5%～10%。最近认识到PCOS不仅涉及生殖系统,而且是一种代谢综合征,常发生高胰岛素血症(High Insulin,HI)、高血脂、糖尿病和心血管疾病,在治疗上涉及月经失调、生育问题、内膜增生、远期代谢合并征等多学科问题。PCOS患者中大约50%超重或肥胖,该型患者代谢紊乱发病率明显高于非肥胖型,而且程度也重于非肥胖型患者。然而肥胖型PCOS患者的治疗仍相当棘手。中医学认为“脾虚不运,痰湿阻滞”为肥胖之根本,现代研究表明这也是PCOS患者胰岛素抵抗(insulinresistance,IR)和代谢紊乱发生的重要病理基础。
近年来随着对PCOS病因病机研究的不断深入,学者们发现PCOS患者不仅存在脂肪量的增多,同时还存在脂肪细胞因子分泌的异常,脂肪中分泌的多种激素信号调节分子与PCOS导致的代谢紊乱及内分泌紊乱存在一定的关系。本组主要通过观察痰湿证PCOS肥胖患者的体重指数(body mass index,BMI)、月经异常、痤疮及多毛评分情况,同时检测促卵泡激素(follicle-stimulating hormone,FSH)、促黄体激素(luteinizing hormone,LH)、睾酮(testosterone,T)、空腹血糖(fasting serumglucose,FPG)、空腹胰岛素(fasting serum insulin,FINS)、瘦素、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α),计算胰岛素敏感指数(insulin insentiveindex,ISI),并以痰湿肥胖体质妇女及非肥胖妇女为对照,旨在探讨痰湿证PCOS肥胖患者血清瘦素、TNF-α水平与IR的关系。
方法
选择2007年1月～2008年1月就诊于广州中医药大学第一附属医院妇科门诊及广东省第二中医院针灸减肥门诊就诊,确诊为痰湿证且肥胖的PCOS患者22例,平均年龄27.55岁。选择同期来针灸门诊减肥的年龄匹配的痰湿肥胖体质者20例(肥胖对照组),及前来体检的健康非肥胖妇女(非肥胖对照组)20例作为对照组。
观察指标:
1、观察并记录所有研究对象的一般情况,测量身高、体重,计算BMI,同时记录月经异常(月经稀发或闭经)、痤疮及多毛评分情况。
2、检测指标所有研究对象均于月经第3~5天(PCOS闭经者B超检查无优势卵泡)晨,空腹抽取肘静脉血8ml,检测FSH、LH、T、FPG、FINS、瘦素、TNF-α。计算ISI,计算方法:ISI=1/(FINS×FPG),ISI＜0.021为IR。
结果
1、痤疮评分在痰湿PCOS组明显高于肥胖对照组及非肥胖对照组(P＜0.05),在肥胖对照组、非肥胖对照组之间比较,差异无显著性(P＞0.05)。多毛评分在痰湿PCOS组、肥胖对照组明显高于非肥胖对照组(P＜0.05),在痰湿PCOS组、肥胖对照组之间比较,差异无显著性(P＞0.05)。
2、LH在痰湿PCOS组明显高于肥胖对照组及非肥胖对照组(P＜0.05),在肥胖对照组及非肥胖对照组间比较,差异无显著性(P＞0.05);FSH、LH/FSH在三组妇女间比较,差异无显著性(P＞0.05);T在痰湿PCOS组明显高于肥胖对照组及非肥胖对照组(P＜0.05),在肥胖对照组、非肥胖对照组之间比较,差异无显著性(P＞0.05)。
3、FPG在三组之间比较差异无显著性(P＞0.05);FINS在痰湿PCOS组明显高于肥胖对照组及非肥胖对照组(P＜0.05),在肥胖对照组明显高于非肥胖对照组(P＜0.05);ISI在痰湿PCOS组明显低于肥胖对照组及非肥胖对照组(P＜0.05),在肥胖对照组明显低于非肥胖对照组(P＜0.05)。
4、血清瘦素、TNF-α在痰湿PCOS组明显高于肥胖对照组及非肥胖对照组(P＜0.05),在肥胖对照组明显高于非肥胖对照组(P＜0.05)。
5、痰湿证PCOS肥胖患者瘦素水平与BMI呈显著正相关关系;与ISI呈显著负相关关系。TNF-α水平与BMI呈显著正相关关系;与ISI呈显著负相关关系。
结论
1、痰湿证PCOS肥胖患者具备HA、HI、IR。
2、痰湿证PCOS肥胖患者瘦素、TNF-α水平升高,与IR的发生关系密切。
Objectivs
Polycystic ovary syndrome(PCOS)is a common gynecologyical disease which can cause endocrinologic disorder and infertility in women of reproductive age,and its incidence is 5%～10%.It is also a kind of metabohsmsyndrome(MS),which has the feature of endocrinology such as High Insulin(HI),insulin resistance(IR),and can lead to Diabetes, Cardiovascular diseas.
Nearly 50%patients of PCOS is obese,who is easy to occurrence MS, and the treatment is difficult.Acorrding to the theroy of Traditional Chinese Medicine,"dysfucnction of spleen and phlegm stagnation" is the basis of obesity,and modern medcin also certificate that it' s the important patholoical basis of PCOS.
Now scholars find that fat cytokines is disorder in patiets with PCOS. The study is to ivestigate the the correlation of leptin,Tumor necrosis factor(TNF)-αwith insulin resistance in patients with PCOS of phlegmatic hygrosis.
Methods
Three groups were established,PHP group(22 cases with PCOS of phlegmatic hygrosis),OB group(20 cases with obese of phlegmatic hygrosis women),NOB group(20 cases with non-obese and healthy women).Condition of menstruation,acne,hairness Were observed,as the serum follicle-stimulating hormone(FSH),luteinizing hormone(LH), testosterone(T),fasting serum glucose(FPG),fasting serum insulin (FINS),leptin,TNF-αwere detected,and insulin sensitivity index(ISI), body mass index(BMI)were calculated.
Results
1.Acne score in PHP group was higher than that in OB group and NOB group(P＜0.05),and had no significant difference between the two controll group(P＞0.05).Hairness score in PHP group and OB group was was higher than that in NOB group(P＜0.05),and had no significant difference between PHP group and OB group(P＞0.05)
2.LH,T in PHP group was higher than that in OB group and NOB group (P＜0.05),and had no significant difference between the two controll group(P＞0.05).FSH,LH/FSH had no significant difference in three groups (P＞0.05).
3.FPG had no significant difference in three groups(P＞0.05).FINS in PHP group was higher than that in OB group and NOB group(P＜0.05), FINS in OB group was higher than that in NOB group(P＜0.05).ISI in PHP group was lower than that in OB group and NOB group(P＜0.05),ISI in OB group was lower than that in NOB group(P＜0.05).
4.Leptin,TNF-αin PHP group was higher than that in OB group and NOB group(P＜0.05),Leptin,TNF-αin OB group was higher than that in NOB group(P＜0.05).
5.Leptin,TNF-αhad direct ratio with BMI,as had negative ratio with ISI.
Conclusions
1.Obese patients with PCOS of phlegmatic hygrosis has the feature of endocrinology such as High Insulin(HI),insulin resistance(IR).
2.Leptin,TNF-αincreases in obses patients with PCOS of phlegmatic hygrosis.Leptin,TNF-αhas close correlation with obesity and IR in obese patients with PCOS of phlegmatic hygrosis.
引文
[1]Diamanti K E,Kouli CR,Bergiele A T,et al.A survey of the polycystic ovary syndrome in the Greek island of Lesbos:hormonal and metabolic,profile[J].J Clin Endocrinol Metab,1999;84:4006-4011.
[2]Yen SSC,Chancy C,Judd HL.Functional aberrations of the hypothalamic-pituitary system in polycystic ovary syndrom e:A consideration of the pathogenesis[A].In:Serio M.The endocrine function of the human ovary[M].New York:Academic Press.1976.373-383.
[3]Burghen GA,Givens JR,Kitabchi AE.Correlation of hyperandregenism with hyperinsulinism in polycystic ovary syndrome[J].J Clin Endocrinol Metab,1980;50(1):113-136.
[4]Zawadzki JK,Dunaif A.Diagnostic criteria:Towards a rational approach[A].In:Hershmann JM.Current issues in endocrinology and metabolism[M].Bosten:Blackwell Scientific Publications,1992.377-384.
[5]Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Revised 2003consensus on diagnostic creteria and longterm health risks to polycystic ovary syndrome[J].Hum Reprod,2004,19(1):41-47.
[6]李美芝.多囊卵巢综合征的诊断与治疗[J].中华妇产科杂志,2002,37(7):444-446。
[7]Ovalle F,Azziz R.Insulin resistance,polycystic ovary syndrome,and type 2diabetes mellitus[J].Fertil Steril,2002,77(6):1095-1105.
[8]戴婷.多囊卵巢综合征IR的新进展[J].复旦学报(医学版),2006,33(2):279-282。
[9]Piltonen T,Koivunen R,Rerheentupa A,et al.The enhanced androgen secretion in polycystic ovary syndrome persist the whole reproductive life[J].Abstracts of the 19 Annual Meeting of ESHRE,Madrid,Spain,2003,43.
[10]季银芬,石一复.多囊卵巢综合征的现状与研究进展[J].国外医学妇幼保健分册2005,16(3):175-178。
[11]Dunaif A.Hyperandrogenic anovulation(PCOS):a unique disorder of insulin action associated wit h an increased risk of on-insulin-dependent diabetes mellitus[J].Am J Med,1995,98:33.
[12]Maciel GA,Soares Junior JM,Alves DA,et al.Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin[J].Fertil and Steril,2004,81(2):355.
[13]焦永慧.多囊卵巢综合征与IR研究进展[J].国外医学计划生育/生殖健康分册,2006,25(3):167-170。
[14]Reaven GM.Pathophysiology of insulin resistance in humandisease[J].Physiol Rev,1995,75(3):473.
[15]Diamanti.Kandarakis E,Bailiargeon JP,Iuomo MJ,eta.A modem medical quandary:polyeystie ovary syndrome,insulin resistance,and pral contraceptive pills[J].J Clin Endocrinol Metab,2003,88(5):1927-1932.
[16]宁光.多囊卵巢综合征的发生机制及诊治进展[J].中国实用内科杂志,2006,26(20):1656-1659。
[17]韩玉昆,宋学茹,张慧英等.多囊卵巢综合征患者代谢特征分析[J].中华妇幼保健,2006,012(3):182。
[18]史轶蘩主编.肥胖不孕症临床诊治手册.上海:上海科学技术出版社,2001,1。
[19]Hoeger K.Obesity and weight loss in polycystic ovary syndrome.Obstect Gynecol Clin North Am,2001,28(1):85.
[20]曹泽毅主编.中华妇产科学.北京:人民卫生出版社,1999,2176。
[21]牛建昭.现代中西医妇科学.北京:中国科学技术出版社,1996,113-114。
[22]高小亚,戈敏娟,马向华.单纯性肥胖患者血清瘦素、抵抗素和脂联素水平的研究[J].医学研究生学报,2006,19(6):544。
[23]孙袁,王彦德,施晓均,等.多囊卵巢综合征患者瘦素水平的测定及临床意义[J].中国妇幼保健,2004,19(5):39。
[24]Moschos S,Chan JL,Mantzoros LS.Leptin and reproduction:a review.Fetil Steril,2002,77(3):433-444.
[25]Zachow RJ,Magoffin DA.Direct intraovarian effects of leptin:Impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulatin hormone-depent estradio-17 β production by rat ovarian gra-nulose cels.Endocrinology,1997,138(2):847-850.
[26]Jin L,Zhang S,Burguera BG,et al.Leptin and leptin receptor expression in rat and mouse pituitary cells.Endocrinology,2000,141(1):333-339.
[27]Oksanen L,Tiitinen A,gaprio J,et al.No evidence for mutations of the leptin or leptin receptor genes in women with polycystic ovary syndrome.Mol Hum Reprod,2000,6(10):873-876.
[28]Erturk E,Kuru N,Savci V,et al.Serum leptin levesl correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome.Fetil Steril,2004,82(5):1364-1368.
[29]Telli MH,Yildirim M,Noyan V.Serum leptin levels in patients with polycystic ovary syndrome.Fetil Steril,2002,77(5):932-935.
[30]孙秀芳,张继英.肥胖与非肥胖型多囊卵巢综合征患者的临床特征临床研究[J].中国医药导报,2007,4(24):34-35。
[31]Morales AJ,Laughlin GA,ButzowT,et al.Insulin,somatotropic and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome:common and distinct features[J].J Clin Endocrinol Meteb,1996,81(8):2854-2864.
[32]Ciampelli M,Lanzone A.Insulin and polycystic ovary syndrome:a new look at an old subject[J].Gynecol Endocrinol,1998,12(4):277.
[33]Hotamialigil GS,Shargill NS,Spiegelman BM Adilx,se expression of tumor necrosisfactor-alpha:direct rolein obesity-linked insulin resistance.Science,1993,259(5091):87.
[34]邹谦,孙明芹.多囊卵巢综合征患者血清TNF-α的检测及意义.河北医学,2005,11(10):907。
[35]Sayin NC,Gucer F,Balkanli-kaplan,et al.Elevate serum TNF-α levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome.J Reprod Med,2003,48(3):165-170.
[36]Peral B,Millan JLS,Castello R,et al.The methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene(TNFRSFIB)is associated with the polycystic ovary syndrome and hyperandrogenism.J Clin Endocrinol Metab,2002,87(8):3971-3983.
[37]Gonzalez F,Thusu K,Abdel-Rahman E,et al.Elevated serum levels of tumor necrosis factor alpha in normal weight women with polycystic ovary syndrome.Metabolism,1999,48(4):437-441.
[38]陈利生,陈守信,倪雅莲,等.自拟“导痰助孕丸”治疗多囊卵巢综合征58例分析[J].铁道医学,1997,25(6):374-375.
[39]桑海莉,王洪芝.补肾活血片治疗多囊卵巢综合征临床研究[J].山东中医杂 志,1998,17(3):104。
[40]付灵敏,马红霞,尤昭玲.论治多囊卵巢综合征的经验[J].福建中中医信息,2003,20(1):39-41。
[41]黎小斌,李丽芸.导痰种子方联合克罗米芬治疗多囊卵巢综合征[J].实用医学杂志,2000,16(4):330-331。
[42]贾金英.加味补中益气汤治疗多囊卵巢综合征43例[J].河南中医,1999,18(6):376。
[43]史莲花,韩宁,褚玉霞.治疗多囊卵巢综合征经验[J].四川中医,2004,22(1):1。
[44]万朝霞,淡勇.治疗多囊卵巢综合征的临床经验[J].黑龙江中医药,2003,5(1):31。
[45]马素侠,李之良,周玲,等.六味地黄丸加味治疗多囊卵巢综合征疗效分析[J].新疆中,2000,18(3):22-23。
[46]王东梅,赵珂.多囊卵巢综合征中医证候分布规律研究[J].山东中医杂志,2006,25(6):378-380。
[47]张鲜桃.辨证治疗多囊卵巢综合征[J].四川中医,2004,22(5):63-64。
[48]俞瑾.多囊卵巢综合征的中西医治疗[J].中国实用妇科与产科杂志,2002,18(11):651-653。
[49]徐宏生,万瑞雄.浅谈中医诊治多囊卵巢综合征[J].湖北中医杂志,1998,20(5):33。
[50]夏阳.苍附导痰汤加减治疗肥胖型多囊卵巢综合征30例[J].天津中医药,2004,21(2):169。
[51]宁美华,刘艳娟,宁喜光.益肾消瘕方治疗多囊卵巢综合征85例小结[J].湖南中医药导报,2004,10(3):27-28。
[52]王砚琳.补肾活血化痰方治疗多囊卵巢综合征所致不孕的临床观察[J].中医药 学刊,2005,23(8):1519-1520。
[53]张海峰.归芍地黄汤合越鞠丸治疗多囊卵巢综合征60例[J].实用中医药杂志,2004,20(2):70。
[54]李广文,王东梅.多囊卵巢综合征[M]//肖承惊.现代中医妇科治疗学.北京:人民卫生出版社,2004:137-138。
[55]田萍,朱三平,李力.启宫丸加减治疗多囊卵巢综合征30例[J].河南中医,1999,19(3):44。
[56]蔡爱华.盛玉凤治疗多囊卵巢综合征的经验[J].现代中西医结合杂志,2004,13(11):1488-1489。
[57]梅彬,胡思专.中西医结合治疗多囊卵巢综合征[J].湖北中医杂志,2001,23(11):38。
[58]叶利群.中医周期疗法加二甲双胍治疗多囊卵巢综合征62例[J].江西中医药,2004,35(2):22-23。
[59]袁雄芳.中医周期疗法治疗多囊卵巢综合征38例[J].福建中医药,2003,34(2):22。
[60]孙永生,赵岩,王秀霞.卵巢Ⅱ号对多囊卵巢大鼠卵巢形态学的影响[J].中医药信息,2002,19(3):70。
[61]郝琦蓉,张引华.多囊平胶囊治疗多囊卵巢综合征的实验研究[J].山西医科大学学报,2003,34(5):447。
[62]孙斐,俞瑾,张利能,等.中药天癸方对雄激素致不孕大鼠下丘脑Leptin受体及神经肽YmRNA的影响[J].中国中西医结合杂志,2000,20(5):362。
[63]骆斌,王琦.痰湿体质论析[J].安徽中医学院学报,1999,18(5):10-12。
[64]王琦.中医体质学.北京:中国医药科技出版社,1995:96-195。
[65]宋咏梅.痰湿体质形成的影响因素[J].山东中医药大学学报,2002,26(2): 100-101。
[66]乔振刚,韩冠先.实用中医痰病证治[M].北京:人民卫生出版社.2002.124。
[67]胡文豪.高脂血症从痰瘀论治[J],上海中医杂志,1985,(3):22。
[68]李美芝主编.妇科内分泌学.第1版.北京:人民军医出版社.2001,197。
[69]张玉珍主编.中医妇科学.第1版.北京:中国中医药出版社.2002,9。
[70]李光伟.胰岛紊敏感性评估及其在临床研究中的应用[J].中华内分泌代谢杂志,2000,16(3):198。
[71]张超群.从流行病学探讨肥人多痰[J].北京中医学院学报,1990,13(4):9。
[72]杜海燕.多囊卵巢综合征与痰湿体质的关系[J].现代中医药,2007,27(3):54-55。
[73]林金芳,李昕,朱铭伟.多囊卵巢综合征的分型探讨[J].中华妇产科杂志,2006,41(10):684-688。
[74]李琳,杨冬梓,冯淑英.体重超重对多囊卵巢综合征患者内分泌改变的影响[J].实用妇产科杂志,2005,21(9):538。
[75]李昕,林金芳.肥胖型多囊卵巢综合征患者临床及内分泌代谢特征的研究[J].中华医学杂志,2005,85(46):3266。
[76]李美芝.妇科内分泌学[M].北京:人民军医出版社,2001.212。
[77]Gambineril A,Pelusil C,Vicennatil V,et al.Obesity and the polycystic ovary syndrome.Int J Obesity,2002,26:883-896.
[78]Vanky E,Kjotrod S,Salvesent KA,et al.Clinical,biochemical and ultrasonograpgic characteristics of Scandinavian women with PCOS.Acta Obstetet Gynecol Scand,2004,83(5):482-486.
[79]Barzilai N,Wang J,Massioln D,et al.Leptin selesctively decreases visceral adiposity and enhances insulin action.J Clin Invest,1997,100:3105-3110.
[80]赵波,邵明君,陈黎.瘦素与多囊卵巢综合征的相关研究[J].浙江临床医学,2007,9(7):889-890。
[81]杨卉,曹缵孙.多囊卵巢综合征IR与瘦素关系的探讨[J].中国实用妇科与产科杂志,2002,18(7):403-405。
[82]王维敏,马向华.代谢综合征患者瘦素抵抗的研究[J].医学研究生报,2004,17(7):610-612。
[83]叶玲玲,曹文丽,姜雯.多囊卵巢综合征患者血瘦素与INS水平关系的探讨[J].现代预防医学,2007,34(7):1376-1378。
[84]肖云武.瘦素、胰岛素抵抗与体脂分布[J].国外医学生理病理科学与临床分册,2001.21:53-55。
[85]Spaczynski RZ,Arici A,Duleba AJ.Tumor necrosis factor-[alpha]stimulates proliferation of rat ovarian theca-interstitial cells[J].Biol Reprod,1999,61:993-998.
[2]Yen SSC,Chancy C,Judd HL.Functional aberrations of the hypothalamic-pituitary system in polycystic ovary syndrom e:A consideration of the pathogenesis[A].In:Serio M.The endocrine function of the human ovary[M].New York:Academic Press.1976.373-383.
[3]Burghen GA,Givens JR,Kitabchi AE.Correlation of hyperandregenism with hyperinsulinism in polycystic ovary syndrome[J].J Clin Endocrinol Metab,1980;50(1):113-136.
[4]Zawadzki JK,Dunaif A.Diagnostic criteria:Towards a rational approach[A].In:Hershmann JM.Current issues in endocrinology and metabolism[M].Bosten:Blackwell Scientific Publications,1992.377-384.
[5]Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Revised 2003consensus on diagnostic creteria and longterm health risks to polycystic ovary syndrome[J].Hum Reprod,2004,19(1):41-47.
[6]李美芝.多囊卵巢综合征的诊断与治疗[J].中华妇产科杂志,2002,37(7):444-446。
[7]Ovalle F,Azziz R.Insulin resistance,polycystic ovary syndrome,and type 2diabetes mellitus[J].Fertil Steril,2002,77(6):1095-1105.
[8]戴婷.多囊卵巢综合征IR的新进展[J].复旦学报(医学版),2006,33(2):279-282。
[9]Piltonen T,Koivunen R,Rerheentupa A,et al.The enhanced androgen secretion in polycystic ovary syndrome persist the whole reproductive life[J].Abstracts of the 19 Annual Meeting of ESHRE,Madrid,Spain,2003,43.
[10]季银芬,石一复.多囊卵巢综合征的现状与研究进展[J].国外医学妇幼保健分册2005,16(3):175-178。
[11]Dunaif A.Hyperandrogenic anovulation(PCOS):a unique disorder of insulin action associated wit h an increased risk of on-insulin-dependent diabetes mellitus[J].Am J Med,1995,98:33.
[12]Maciel GA,Soares Junior JM,Alves DA,et al.Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin[J].Fertil and Steril,2004,81(2):355.
[13]焦永慧.多囊卵巢综合征与IR研究进展[J].国外医学计划生育/生殖健康分册,2006,25(3):167-170。
[14]Reaven GM.Pathophysiology of insulin resistance in humandisease[J].Physiol Rev,1995,75(3):473.
[15]Diamanti.Kandarakis E,Bailiargeon JP,Iuomo MJ,eta.A modem medical quandary:polyeystie ovary syndrome,insulin resistance,and pral contraceptive pills[J].J Clin Endocrinol Metab,2003,88(5):1927-1932.
[16]宁光.多囊卵巢综合征的发生机制及诊治进展[J].中国实用内科杂志,2006,26(20):1656-1659。
[17]韩玉昆,宋学茹,张慧英等.多囊卵巢综合征患者代谢特征分析[J].中华妇幼保健,2006,012(3):182。
[18]史轶蘩主编.肥胖不孕症临床诊治手册.上海:上海科学技术出版社,2001,1。
[19]Hoeger K.Obesity and weight loss in polycystic ovary syndrome.Obstect Gynecol Clin North Am,2001,28(1):85.
[20]曹泽毅主编.中华妇产科学.北京:人民卫生出版社,1999,2176。
[21]牛建昭.现代中西医妇科学.北京:中国科学技术出版社,1996,113-114。
[22]高小亚,戈敏娟,马向华.单纯性肥胖患者血清瘦素、抵抗素和脂联素水平的研究[J].医学研究生学报,2006,19(6):544。
[23]孙袁,王彦德,施晓均,等.多囊卵巢综合征患者瘦素水平的测定及临床意义[J].中国妇幼保健,2004,19(5):39。
[24]Moschos S,Chan JL,Mantzoros LS.Leptin and reproduction:a review.Fetil Steril,2002,77(3):433-444.
[25]Zachow RJ,Magoffin DA.Direct intraovarian effects of leptin:Impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulatin hormone-depent estradio-17 β production by rat ovarian gra-nulose cels.Endocrinology,1997,138(2):847-850.
[26]Jin L,Zhang S,Burguera BG,et al.Leptin and leptin receptor expression in rat and mouse pituitary cells.Endocrinology,2000,141(1):333-339.
[27]Oksanen L,Tiitinen A,gaprio J,et al.No evidence for mutations of the leptin or leptin receptor genes in women with polycystic ovary syndrome.Mol Hum Reprod,2000,6(10):873-876.
[28]Erturk E,Kuru N,Savci V,et al.Serum leptin levesl correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome.Fetil Steril,2004,82(5):1364-1368.
[29]Telli MH,Yildirim M,Noyan V.Serum leptin levels in patients with polycystic ovary syndrome.Fetil Steril,2002,77(5):932-935.
[30]孙秀芳,张继英.肥胖与非肥胖型多囊卵巢综合征患者的临床特征临床研究[J].中国医药导报,2007,4(24):34-35。
[31]Morales AJ,Laughlin GA,ButzowT,et al.Insulin,somatotropic and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome:common and distinct features[J].J Clin Endocrinol Meteb,1996,81(8):2854-2864.
[32]Ciampelli M,Lanzone A.Insulin and polycystic ovary syndrome:a new look at an old subject[J].Gynecol Endocrinol,1998,12(4):277.
[33]Hotamialigil GS,Shargill NS,Spiegelman BM Adilx,se expression of tumor necrosisfactor-alpha:direct rolein obesity-linked insulin resistance.Science,1993,259(5091):87.
[34]邹谦,孙明芹.多囊卵巢综合征患者血清TNF-α的检测及意义.河北医学,2005,11(10):907。
[35]Sayin NC,Gucer F,Balkanli-kaplan,et al.Elevate serum TNF-α levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome.J Reprod Med,2003,48(3):165-170.
[36]Peral B,Millan JLS,Castello R,et al.The methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene(TNFRSFIB)is associated with the polycystic ovary syndrome and hyperandrogenism.J Clin Endocrinol Metab,2002,87(8):3971-3983.
[37]Gonzalez F,Thusu K,Abdel-Rahman E,et al.Elevated serum levels of tumor necrosis factor alpha in normal weight women with polycystic ovary syndrome.Metabolism,1999,48(4):437-441.
[38]陈利生,陈守信,倪雅莲,等.自拟“导痰助孕丸”治疗多囊卵巢综合征58例分析[J].铁道医学,1997,25(6):374-375.
[39]桑海莉,王洪芝.补肾活血片治疗多囊卵巢综合征临床研究[J].山东中医杂 志,1998,17(3):104。
[40]付灵敏,马红霞,尤昭玲.论治多囊卵巢综合征的经验[J].福建中中医信息,2003,20(1):39-41。
[41]黎小斌,李丽芸.导痰种子方联合克罗米芬治疗多囊卵巢综合征[J].实用医学杂志,2000,16(4):330-331。
[42]贾金英.加味补中益气汤治疗多囊卵巢综合征43例[J].河南中医,1999,18(6):376。
[43]史莲花,韩宁,褚玉霞.治疗多囊卵巢综合征经验[J].四川中医,2004,22(1):1。
[44]万朝霞,淡勇.治疗多囊卵巢综合征的临床经验[J].黑龙江中医药,2003,5(1):31。
[45]马素侠,李之良,周玲,等.六味地黄丸加味治疗多囊卵巢综合征疗效分析[J].新疆中,2000,18(3):22-23。
[46]王东梅,赵珂.多囊卵巢综合征中医证候分布规律研究[J].山东中医杂志,2006,25(6):378-380。
[47]张鲜桃.辨证治疗多囊卵巢综合征[J].四川中医,2004,22(5):63-64。
[48]俞瑾.多囊卵巢综合征的中西医治疗[J].中国实用妇科与产科杂志,2002,18(11):651-653。
[49]徐宏生,万瑞雄.浅谈中医诊治多囊卵巢综合征[J].湖北中医杂志,1998,20(5):33。
[50]夏阳.苍附导痰汤加减治疗肥胖型多囊卵巢综合征30例[J].天津中医药,2004,21(2):169。
[51]宁美华,刘艳娟,宁喜光.益肾消瘕方治疗多囊卵巢综合征85例小结[J].湖南中医药导报,2004,10(3):27-28。
[52]王砚琳.补肾活血化痰方治疗多囊卵巢综合征所致不孕的临床观察[J].中医药 学刊,2005,23(8):1519-1520。
[53]张海峰.归芍地黄汤合越鞠丸治疗多囊卵巢综合征60例[J].实用中医药杂志,2004,20(2):70。
[54]李广文,王东梅.多囊卵巢综合征[M]//肖承惊.现代中医妇科治疗学.北京:人民卫生出版社,2004:137-138。
[55]田萍,朱三平,李力.启宫丸加减治疗多囊卵巢综合征30例[J].河南中医,1999,19(3):44。
[56]蔡爱华.盛玉凤治疗多囊卵巢综合征的经验[J].现代中西医结合杂志,2004,13(11):1488-1489。
[57]梅彬,胡思专.中西医结合治疗多囊卵巢综合征[J].湖北中医杂志,2001,23(11):38。
[58]叶利群.中医周期疗法加二甲双胍治疗多囊卵巢综合征62例[J].江西中医药,2004,35(2):22-23。
[59]袁雄芳.中医周期疗法治疗多囊卵巢综合征38例[J].福建中医药,2003,34(2):22。
[60]孙永生,赵岩,王秀霞.卵巢Ⅱ号对多囊卵巢大鼠卵巢形态学的影响[J].中医药信息,2002,19(3):70。
[61]郝琦蓉,张引华.多囊平胶囊治疗多囊卵巢综合征的实验研究[J].山西医科大学学报,2003,34(5):447。
[62]孙斐,俞瑾,张利能,等.中药天癸方对雄激素致不孕大鼠下丘脑Leptin受体及神经肽YmRNA的影响[J].中国中西医结合杂志,2000,20(5):362。
[63]骆斌,王琦.痰湿体质论析[J].安徽中医学院学报,1999,18(5):10-12。
[64]王琦.中医体质学.北京:中国医药科技出版社,1995:96-195。
[65]宋咏梅.痰湿体质形成的影响因素[J].山东中医药大学学报,2002,26(2): 100-101。
[66]乔振刚,韩冠先.实用中医痰病证治[M].北京:人民卫生出版社.2002.124。
[67]胡文豪.高脂血症从痰瘀论治[J],上海中医杂志,1985,(3):22。
[68]李美芝主编.妇科内分泌学.第1版.北京:人民军医出版社.2001,197。
[69]张玉珍主编.中医妇科学.第1版.北京:中国中医药出版社.2002,9。
[70]李光伟.胰岛紊敏感性评估及其在临床研究中的应用[J].中华内分泌代谢杂志,2000,16(3):198。
[71]张超群.从流行病学探讨肥人多痰[J].北京中医学院学报,1990,13(4):9。
[72]杜海燕.多囊卵巢综合征与痰湿体质的关系[J].现代中医药,2007,27(3):54-55。
[73]林金芳,李昕,朱铭伟.多囊卵巢综合征的分型探讨[J].中华妇产科杂志,2006,41(10):684-688。
[74]李琳,杨冬梓,冯淑英.体重超重对多囊卵巢综合征患者内分泌改变的影响[J].实用妇产科杂志,2005,21(9):538。
[75]李昕,林金芳.肥胖型多囊卵巢综合征患者临床及内分泌代谢特征的研究[J].中华医学杂志,2005,85(46):3266。
[76]李美芝.妇科内分泌学[M].北京:人民军医出版社,2001.212。
[77]Gambineril A,Pelusil C,Vicennatil V,et al.Obesity and the polycystic ovary syndrome.Int J Obesity,2002,26:883-896.
[78]Vanky E,Kjotrod S,Salvesent KA,et al.Clinical,biochemical and ultrasonograpgic characteristics of Scandinavian women with PCOS.Acta Obstetet Gynecol Scand,2004,83(5):482-486.
[79]Barzilai N,Wang J,Massioln D,et al.Leptin selesctively decreases visceral adiposity and enhances insulin action.J Clin Invest,1997,100:3105-3110.
[80]赵波,邵明君,陈黎.瘦素与多囊卵巢综合征的相关研究[J].浙江临床医学,2007,9(7):889-890。
[81]杨卉,曹缵孙.多囊卵巢综合征IR与瘦素关系的探讨[J].中国实用妇科与产科杂志,2002,18(7):403-405。
[82]王维敏,马向华.代谢综合征患者瘦素抵抗的研究[J].医学研究生报,2004,17(7):610-612。
[83]叶玲玲,曹文丽,姜雯.多囊卵巢综合征患者血瘦素与INS水平关系的探讨[J].现代预防医学,2007,34(7):1376-1378。
[84]肖云武.瘦素、胰岛素抵抗与体脂分布[J].国外医学生理病理科学与临床分册,2001.21:53-55。
[85]Spaczynski RZ,Arici A,Duleba AJ.Tumor necrosis factor-[alpha]stimulates proliferation of rat ovarian theca-interstitial cells[J].Biol Reprod,1999,61:993-998.